(Q34546104)

2 August 2017

1 reference

title

Pathogenesis of retinopathy of prematurity. (English)

1 reference

2 August 2017

Lois E H Smith

1

1 reference

2 August 2017

1 December 2003

1 reference

Seminars in Fetal and Neonatal Medicine

2 August 2017

1 reference

2 August 2017

8

1 reference

2 August 2017

469-473

1 reference

2 August 2017

6

1 reference

Prevention of retrolental fibroplasia

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Retinal Vascular Development in Premature Infants

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies. The XX Francis I. Proctor Lecture.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Recovery from retinopathy in a case of diabetes with Simmonds' disease

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Essential role of growth hormone in ischemia-induced retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2803%2900119-2

7 January 2021

10.1016/S1084-2756(03)00119-2

Identifiers

DOI

1 reference

release_iiodrbo4kbgh7j3gmh5efeo2lm

2 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iiodrbo4kbgh7j3gmh5efeo2lm

24 November 2022

mapped directly with Wikidata item

PubMed ID

15001119

1 reference

PubMed ID

15001119